ENTITY
Seagen

Seagen (SGEN US)

40
Analysis
Health CareUnited States
Seagen Inc. operates as a biotechnology company. The Company discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases, as well as offers antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. Seagen serves customers worldwide.
more
Company Presentation16 Feb 2023 05:30
Company Presentation28 Oct 2022 04:30
Company Presentation28 Jul 2022 09:09
Company Presentation29 Apr 2022 00:40
Company Presentation09 Feb 2022 22:50
x